Peer-Reviewed Library

KOELIS™ has assisted physicians in USA and around the world in their routine clinical practice since 2006, providing the latest fusion biopsy technology for personalized prostate cancer planning and management. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of KOELIS™ technology.

You will find below the best published results. Please visit The National Library of Medicine for complete full-text articles. At our image library, you will find several clinical publications’ infographics.

Efficiency in PCA Detection

Transrectal Ultrasound-Guided Prostate Biopsy for Cancer Detection: Performance of 2D-, 3D- and 3D-MRI Fusion Targeted Techniques.

Klein J., Urol Int. 2017;98(1):7-14.

 

Detection of prostate cancer using magnetic resonance imaging/ultrasonography image-fusion targeted biopsy in African-American men.

Shin T., BJU Int. 2017 Aug;120(2):233-238.

 

Comparative Effectiveness of Targeted Prostate Biopsy Using Magnetic Resonance Imaging Ultrasound Fusion Software and Visual Targeting: a Prospective Study.

Lee DJ., J Urol. 2016 Sep;196(3):697-702.

 

A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy.

Baco E., Eur Urol. 2016 Jan;69(1):149-56.

 

Results of a comparative analysis of magnetic resonance imaging-targeted versus three-dimensional transrectal ultrasound prostate biopsies: Size does matter.

Peltier A., Scand J Urol. 2016 Jun;50(3):144-8.

 

Gleason Score Determination with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Guided Prostate Biopsies–Are We Gaining in Accuracy?

Lanz C., J Urol. 2016 Jan;195(1):88-93.

 

Magnetic resonance/transrectal ultrasound fusion biopsy of the prostate compared to systematic 12-core biopsy for the diagnosis and characterization of prostate cancer: multi-institutional retrospective analysis of 389 patients.

Mariotti GC., Urol Oncol. 2016 Sep;34(9):416.e9-416.e14.

 

Prostate Cancer Detection Rate with Koelis Fusion Biopsies versus Cognitive Biopsies: A Comparative Study.

Oderda M., Urol Int. 2016;97(2):230-7.

 

MRI-targeted biopsies versus systematic transrectal ultrasound guided biopsies for the diagnosis of localized prostate cancer in biopsy naïve men.

Peltier A., Biomed Res Int. 2015;2015:571708.

 

Accuracy of Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies to Diagnose Clinically Significant Prostate Cancer in Enlarged Compared to Smaller Prostates.

De gorski A., J Urol. 2015 Sep;194(3):669-73.

 

Detection of radiorecurrent prostate cancer using diffusion-weighted imaging and targeted biopsies.

Rud E., AJR Am J Roentgenol 2014 Mar;202(3):W241-6.

MRI Validation in PCA Management

Assessment of Prospectively Assigned Likert Scores for Targeted Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsies in Patients with Suspected Prostate Cancer.

Costa DN., J Urol. 2016 Jan;195(1):80-7.

 

Prostate Cancer Volume Estimation by Combining Magnetic Resonance Imaging and Targeted Biopsy Proven Cancer Core Length: Correlation with Cancer Volume.

Matsugasumi T., J Urol. 2015 Oct;194(4):957-65.

 

First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer.

Mozer P., BJU Int. 2015 Jan;115(1):50-7.

 

Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy.

Renard-Penna R., Radiology. 2015 May;275(2):458-68.

 

MR Imaging-Transrectal US Fusion for Targeted Prostate Biopsies: Implications for Diagnosis and Clinical Management.

Costa DN.,Radiographics. 2015 May-Jun;35(3):696-708.

 

Trans-rectal ultrasound visibility of prostate lesions identified by magnetic resonance imaging increases accuracy of image-fusion targeted biopsies.

Ukimura O., World J Urol. 2015 Nov;33(11):1669-76.

 

Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion.

Fiard G., Urology. 2013 Jun;81(6):1372-8.

 

Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients.

Portalez D., Eur Urol. 2012 Dec;62(6):986-96.

 

Value of multiparametric MRI in the work-up of prostate cancer.

Cornud F., Curr Urol Rep. 2012 Feb;13(1):82-92.

Advanced Radiology PET/CT